Silo Pharma, Inc.
SILO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001514183
No open-market purchases or sales by Silo Pharma, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $886.6K in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Silo Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 0 | 4 | +4 |
| Shares | 0 | 50.8K | +50.8K |
| Value | $0 | $273.0K | +$273.0K |
New holders (4)
Institutions that held Silo Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FNY Investment Advisers, LLC | 26,861 | $144.0K | 0.10% |
| Shay Capital LLC | 17,013 | $92.0K | 0.05% |
| UBS Group AG | 6,799 | $37.0K | 0.00% |
| Westside Investment Management, Inc. | 94 | $0 | 0.00% |
Sold out (0)
Institutions that held Silo Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
None.